What is it about?
This review highlights the health problems that are caused by human rhinovirus, the primary agent responsible for causing the common cold. This virus currently has no vaccine or treatment, and we review the molecules and therapeutic approaches that are currently being investigated for treating this virus.
Featured Image
Why is it important?
Human rhinovirus can pose a significant problem for individuals with existing lung diseases such as cystic fibrosis and asthma, and new treatments for combatting it are urgently required. We highlight some recent exciting developments in the field that may finally provide a therapeutic option for treating this viral infection.
Perspectives
There has been some real progress made over the past few years in terms of finding an effective way of treating rhinovirus and the common cold. We felt it appropriate to take this opportunity to highlight the work that has occurred in many groups around the world in terms of finding an effective treatment for this virus. We hope that in the next few years, we will finally see change in how rhinovirus infection is treated.
Peter Barlow
Edinburgh Napier University
Read the Original
This page is a summary of: Antiviral therapeutic approaches for human rhinovirus infections, Future Virology, June 2018, Future Medicine,
DOI: 10.2217/fvl-2018-0016.
You can read the full text:
Contributors
The following have contributed to this page
